Breast cancer statistics, 2017, racial disparity in mortality by state

By C. DeSantis, Jiemin Ma, Ann Goding Sauer, L. Newman, A. Jemal. Ca, 2017

1,483 citations recorded by the source corpus.

In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 252,710 new cases of invasive breast cancer and 40,610 breast cancer deaths are expected to occur among US women in 2017. From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), non‐Hispanic black (NHB) (0.4% per year), and Hispanic (0.3% per year) women but were stable in non‐Hispanic white (NHW) and American Indian/Alaska Native (AI/AN) women. The increasing trends were driven by increases in hormone receptor‐positive breast cancer, which increased among all racial/ethnic groups, whereas rates of hormone receptor‐negative breast cancers decreased. From 1989 to 2015, breast cancer death rates decreased by 39%, which translates to 322,600 averted breast cancer deaths in the United States. During 2006 to 2015, death rates decreased in all racial/ethnic groups, including AI/ANs. However, NHB women continued to have higher breast cancer death rates than NHW women, with rates 39% higher (mortality rate ratio [MRR], 1.39; 95% confidence interval [CI], 1.35‐1.43) in NHB women in 2015, although the disparity has ceased to widen since 2011. By state, excess death rates in black women ranged from 20% in Nevada (MRR, 1.20; 95% CI, 1.01‐1.42) to 66% in Louisiana (MRR, 1.66; 95% CI, 1.54, 1.79). Notably, breast cancer death rates were not significantly different in NHB and NHW women in 7 states, perhaps reflecting an elimination of disparities and/or a lack of statistical power. Improving access to care for all populations could eliminate the racial disparity in breast cancer mortality and accelerate the reduction in deaths from this malignancy nationwide. CA Cancer J Clin 2017;67:439‐448. © 2017 American Cancer Society.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/92b2489320126b25745033e77c18c18fa726636f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. R. Siegel
2. K. Miller
3. A. Jemal

In Oncology

1. R. Siegel
2. A. Jemal
3. K. Miller
4. S. Fedewa
5. H. Salehiniya
6. Zohre Momenimovahed
7. Robert A. Smith
8. F. Bray

Citations in the corpus

• Cancer statistics, 2018 (2018, background): “7% per year among Asian/Pacific Islander women; rates among NHWs and American Indians/Alaska Natives remained stable.(33) Lung cancer incidence rates continue to decline about twice as fast in men as in women, reflecting historical differences in tobacco uptake and cessation, as well as upturns in f”
• Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening (2018, background): “During 2011 through 2015, death rates were 42% higher in black women than in white women.(22) The ACS guideline for breast cancer screening in average-risk women was updated in 2015.”
• Epidemiological characteristics of and risk factors for breast cancer in the world (2019, background): “6,341 cases of breast cancer in situ were diagnosed in the United States.(18) Nearly 24% of all breast cancer cases occur in the Asia-Pacific region, with the highest rates seen in China, Japan, and Indonesia.”